U.S. pharma big copyright scrapped two experimental weight loss pills previous 12 months—a after-day by day tablet, lotiglipron, on account of elevated liver enzymes along with a 2 times-day-to-day tablet, danuglipron, due to potent Negative effects—but CEO Albert Bourla has reported